ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 729813 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 729813; 2) Community: the network communities that were significantly associated with the response to NSC 729813; 3) Molecule: the relationships between components within communities and NSC 729813; 4) MDR: the compounds that were significantly associated with the NSC 729813.

NSC Compound Enrichment Correlation
NSC 374028 Camptothecin Derivative 0.0171439890681608 0.76814005
NSC 38086 Null 0.0171439890681608 0.037342365
NSC 53327 Null 0.0171439890681608 0.24287862
NSC 610458 Camptothecin Derivative 0.0171439890681608 0.78423549
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0171439890681608 0.34783164
NSC 629974 7H-1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine, 3-(4-chlorophenyl)-6-(5-nitro-2-furanyl)- (9CI) 0.0171439890681608 0.15694793
NSC 639174 Camptothecin Derivative 0.0171439890681608 0.69402028
NSC 642954 Null 0.0171439890681608 0.47728157
NSC 661820 Null 0.0171439890681608 0.17557249
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.0171439890681608 0.64693963
Total:63  Current:29    [First] [Prev] [Next] [Last]